DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response

DNA intercalation is a major therapeutic modality for cancer therapeutic drugs. The therapeutic activity comes at a cost of normal tissue toxicity and genotoxicity. We have recently described a planar heterocyclic small molecule DNA intercalator, BMH-21, that binds ribosomal DNA and inhibits RNA pol...

Full description

Saved in:
Bibliographic Details
Main Authors: Colis, Laureen, Peltonen, Karita, Sirajuddin, Paul, Liu, Hester, Sanders, Sara, Ernst, Glen, Barrow, James C., Laiho, Marikki
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2014
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4147329/
https://ncbi.nlm.nih.gov/pubmed/24952786
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items